Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$191.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.68 | 0.97%
Avg Daily Range (30 D):	$1.44 | 1.46%
Avg Daily Range (90 D):	$1.33 | 1.42%

Institutional Daily Volume
Avg Daily Volume:	5.72M
Avg Daily Volume (30 D):	8.48M
Avg Daily Volume (90 D):	9.65M

Trade Size
Avg Trade Size (Sh.):	139
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	104,070
Avg Institutional Trade:	$5.9M
Avg Institutional Trade (30 D):	$14.7M
Avg Institutional Trade (90 D):	$12M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	18

Market Closing Trades
Avg Closing Trade:	$56.63M
Avg Closing Trade (30 D):	$180.34M
Avg Closing Trade (90 D):	$203.95M
Avg Closing Volume:	680.23K

News

Aug 11, 2026 @ 9:30 PM The U.S. Labor Market Is Weakening. These 2 Divide... Source: Prosper Junior Bakiny

Jul 31, 2026 @ 7:29 PM Abbott Laboratories vs. Johnson & Johnson: Which H... Source: Brendan Coffey

Jul 31, 2026 @ 2:18 PM 1 Unstoppable Dividend ETF Up 26% in 2026 to Buy a... Source: Neil Patel

Jul 28, 2026 @ 11:45 AM Implicity’s Next-Generation ILR ECG Analyze... Source: Not Specified

Jul 26, 2026 @ 12:30 PM If I Were Starting My Portfolio From Scratch Today... Source: Matt Dilallo

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$3.1	$.53	$.62
Diluted EPS	$3.09	$.53	$.61
Revenue	$46.59B	$12.59B	$11.16B
Gross Profit	$26.37B	$7.27B	$6.27B
Net Income / Loss	$5.43B	$928M	$1.08B
Operating Income / Loss	$7.35B	$1.69B	$1.35B
Cost of Revenue	$20.21B	$5.33B	$4.89B
Net Cash Flow	$-1824M	$-1703M	$-1696M
PE Ratio